1. As of July, 2023 18, Alnylam statistics show that the success rate of new drug research and development in biomedical industry is 5.5%, the average success rate of targeted drugs is 10, and the success rate of Alnylam can reach 54.6%.
2. Acrolein Aniram Pharmaceutical Company. The company name AlnylamPharmaceuticals, Inc. was listed on May 28th, 2004, and the exchange is Nasdaq Stock Exchange.